Is Applied DNA Sciences, Inc. (APDN) a Buy, Sell, or Hold?
NASDAQ : APDN
Applied DNA Sciences, Inc.
$5.62 USD
$1.35 (31.62%)
- Volume
- 2.65M
- Average Volume
- 469.22K
- Market Capitalization
- $7.26M
- P/E Ratio
- -0.05
- Dividend Yield
- 0.00%
- Price Target
- $1.50
- Year High
- $319.95
- Year Low
- $2.13
- Day High
- —
- Day Low
- —
- Payout Ratio
- -$0.24
- Current Ratio
- $1.82
Company Overview
NASDAQ
James A. Hayward Sc.D.
Medical - Diagnostics & Research
Healthcare
APDN
46
US
USD
Liquidity Metrics
0.00
1.82
1.74
0.64
-0.24
Sales & Valuation
$2.14M
4.69
4.51
-0.54
-1.37
Profitability
-$134.23
-$69.49M
-4197.76%
-2257.24%
-652.52%
-476.10%
P/E Metrics
-0.05
0.00
0.00
Analyst Price Target & Rating
$1.50
$1.50
$1.50
0/5
4 Analysts
274.67%
Financial Health Scores
-36.89
2/9
$1.21M
$13.63M
$1.5M
$6.3M
Key Metrics (TTM)
$6.31M
4.08
0.96
1.82
-652.52%
-288.45%
-118.65%
-183.77%
139 days
Company Executives
| Name | Title |
|---|---|
| James A. Hayward | Chairman & Chief Executive Officer |
| Beth Jantzen | Chief Financial Officer |
| Judith Murrah | President & Secretary |
| Clay Shorrock | Chief Legal Officer & Executive Director of Business Development |
| Sanjay Hurry | Executive Director of Investor Relations & Corporation Communications |
Poll Results
No votes yet today — be the first to share your view!
About Applied DNA Sciences, Inc. (NASDAQ:APDN) Stock
Applied DNA Sciences, Inc. specializes in devising and marketing sophisticated DNA-centric technological solutions across diverse sectors. Its activities encompass nucleic acid-based in vitro diagnostics and the preclinical development and production of nucleic acid-based pharmaceuticals. Furthermore, the company offers robust solutions for bolstering supply chain security, combating counterfeiting, and preventing theft. Key offerings for product authenticity and supply chain integrity include SigNature molecular tags, which imbue products with forensic traceability and protection, thereby strengthening brand defense and supply chain resilience while aiding in criminal identification and prosecution. To facilitate real-time, field-based verification of these tags, they provide SigNify IF p ... ortable DNA readers along with corresponding SigNify consumable reagent test kits. The CertainT platform represents a holistic approach, integrating tagging, testing, and tracking capabilities, empowering manufacturers, brands, and trade organizations to substantiate their product claims with verifiable evidence. Within the diagnostic realm, the company produces the LineaTM COVID-19 Assay Kit, a PCR-based molecular diagnostic test. It also offers the safeCircle COVID-19 diagnostic kit, specifically designed to help curtail viral transmission within communal settings such as schools or workplaces. Additionally, Applied DNA Sciences delivers contract research and manufacturing services for the burgeoning nucleic acid-based therapeutic markets during their preclinical phases. This extends to providing contract research for clients involved in preclinical studies of RNA-based drugs and biologics. The company is also at the forefront of developing an innovative technology for the capture and identification of invasive circulating tumor cells, utilizing a proprietary functional assay to isolate live invasive tumor cells and their associated lymphocytes. Operating internationally, the firm maintains a significant footprint across the United States, Europe, and Asia. Founded in 1983, the organization was initially known as Datalink Systems, Inc., before officially changing its name to Applied DNA Sciences, Inc. in 2002. Its corporate headquarters are located in Stony Brook, New York.
Frequently Asked Questions
-
What is the current Applied DNA Sciences, Inc. (APDN) stock price?
-
Applied DNA Sciences, Inc.(NASDAQ:APDN) stock price is $5.62 in the last trading session. During the trading session, APDN stock reached the peak price of $319.95 while $2.13 was the lowest point it dropped to. The percentage change in APDN stock occurred in the recent session was 31.62% while the dollar amount for the price change in APDN stock was $1.35.
-
APDN's industry and sector of operation?
-
The NASDAQ listed APDN is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of APDN?
-
James A. Hayward | Chairman & Chief Executive Officer
Beth Jantzen | Chief Financial Officer
Judith Murrah | President & Secretary
Clay Shorrock | Chief Legal Officer & Executive Director of Business Development
Sanjay Hurry | Executive Director of Investor Relations & Corporation Communications -
How many employees does APDN have?
-
Number of APDN employees currently stands at 46. APDN operates from 50 Health Sciences Drive, Stony Brook, NY 11790, US.
-
Link for APDN official website?
-
Official Website of APDN is: https://www.adnas.com
-
How do I contact APDN?
-
APDN could be contacted at phone #631 840 8800 and can also be accessed through its website. APDN operates from 50 Health Sciences Drive, Stony Brook, NY 11790, US.
-
How many shares of APDN are traded daily?
-
The average number of APDN shares traded daily for last 3 months was 469.22K.
-
What is the market cap of APDN currently?
-
The market value of APDN currently stands at $7.26M with its latest stock price at $5.62